Cancer patients could avoid unnecessary radiation therapy as a result of an international clinical trial, led by Peter Mac ...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to optimize drug delivery for applications with significant unmet need, ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...

PP02.05 Initial Results from RESOLVE, a Phase 1b Dose-Escalation Study of EP-104GI (Extended-Release Fluticasone ...

Treatment includes pharmacologic therapy, dietary exclusions and mechanical dilatation. As more research identifies the impact of esophageal remodeling and fibrosis, new treatments targeting this ...

Nonselective beta blockers or endoscopic band ligation (EVL) are recommended for primary prophylaxis of variceal bleeding in patients with esophageal ... the pharmacologic treatment of portal ...

New Delhi: Home-grown pharma major Lupin Ltd on Wednesday said it has entered into a non-exclusive patent licence agreement ...

HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...

Soon after my diagnosis, my doctor told me I had two years left to live—if I was lucky. This prognosis was due to the state of my liver function measured by the model for end-st ...